Archives
-
Cy3 Goat Anti-Mouse IgG (H+L) Antibody Workflow
2026-09-29
Build sensitive fluorescence workflows for mapping mouse primary antibodies in adrenal-cell immunofluorescence, flow cytometry, western blotting, and related assays. The Cy3 label is especially useful when the goal is to compare receptor localization, knockdown controls, and pathway-associated phenotypes with consistent image-based quantification.
-
FITC Goat Anti-Rabbit IgG (H+L) Antibody Workflow
2026-09-29
Build sensitive rabbit IgG detection workflows for Leydig-cell and testicular injury studies with a fluorescein-conjugated secondary antibody. This guide connects pathway-focused immunofluorescence, flow cytometry, and fluorescent tissue imaging with practical controls, optimization ranges, and troubleshooting strategies.
-
HA-LNP PTEN mRNA for Transdermal Melanoma Therapy
2026-09-28
This study develops a hyaluronate-conjugated lipid nanoparticle in which HA-DMG replaces conventional PEG-lipid functionality while enabling skin penetration and CD44-directed uptake of PTEN mRNA. In melanoma models, topical PTEN mRNA delivery restored tumor-suppressor expression, promoted immunogenic cell death, activated antitumor responses, and reduced tumor growth with limited observed toxicity.
-
Cy5-Labeled mRNA for Delivery and Translation Assays
2026-09-28
Separate cellular uptake from productive protein expression with a single dual-fluorescence reporter. This practical workflow uses Cy5 to track mRNA and EGFP to assess translation, helping researchers compare delivery conditions without treating fluorescence uptake alone as functional success.
-
ASB3 Targets MAVS to Suppress Antiviral Immunity
2026-09-27
The 2024 study identifies ASB3 as an inducible E3 ubiquitin ligase that weakens antiviral signaling by directing K48-linked ubiquitination and proteasomal degradation of MAVS. Its cell and animal findings connect this molecular mechanism to reduced interferon responses and greater influenza susceptibility, while highlighting MAVS turnover as a point of control in RNA-virus immunity.
-
Hoechst 33342 in Inflammatory Cell Assays
2026-09-26
Hoechst 33342 is more than a nuclear label: it can add cell-level context to studies of epithelial injury and inflammatory signaling. Learn how to use this bis-benzimidazole fluorescent dye alongside pathway and barrier assays—and where its readout must not be overinterpreted.
-
ROS-Responsive Therapy for Diabetic Periodontitis
2026-09-25
A hierarchically targeted nanoparticle–hydrogel platform aims to interrupt the mitochondrial ROS–inflammation cycle in diabetic periodontitis by delivering MitoQ to M1 macrophages. In vitro and rat-model findings support further preclinical study, while leaving questions about clinical transfer, dosing, and long-term safety unresolved.
-
FITC Goat Anti-Mouse IgG (H+L) Antibody Workflows
2026-09-25
Use this FITC-labeled secondary to visualize mouse primary antibodies in immunofluorescence and flow cytometry, including studies of antiviral signaling. A practical workflow connects ASB3–MAVS biology to assay design while emphasizing controls, optimization, and limits on interpretation.
-
Nanobody-TurboID Maps the CD38-Associated Surfaceome
2026-09-24
Feng and colleagues developed nanobody-targeted TurboID (NBID) to label and identify proteins near CD38 on living cell surfaces, combining proximity proteomics with microscopy, SILAC, and migration assays. Their findings outline a CD38-associated adhesion network and link CD38 to tumor–endothelial interactions, while illustrating that proximity labeling identifies molecular neighborhoods rather than proving direct binding.
-
CLEC5A and ISG20 in Atherosclerosis: Causal Evidence
2026-09-24
Zhang et al. combine transcriptomic, eQTL, and Mendelian-randomization evidence to prioritize CLEC5A and ISG20 as genes associated with atherosclerosis risk, then examine their expression in cellular and mouse models. The findings strengthen the case for ISG20 as an inflammation-linked candidate for further study, while leaving the size and mechanism of its causal contribution to be tested more directly.
-
HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody
2026-09-23
This fluorescent secondary antibody detects rabbit primary antibodies in fluorescence-based assays, helping researchers visualize target binding in imaging and flow workflows. It is not a standalone stain or a substitute for a secondary matched to another primary-antibody species; validate dilution, sample preparation, and instrument compatibility before use.
-
ASB3–MAVS Control of Antiviral Immunity
2026-09-23
The 2024 reference study identifies ASB3 as an inducible E3 ligase that weakens antiviral innate immunity by directing K48-linked ubiquitination and proteasomal degradation of MAVS. Its genetic, biochemical, infection, and animal experiments connect ASB3 activity with reduced type I interferon signaling and increased influenza susceptibility, while also suggesting practical readouts for studying this pathway.
-
EZ Cap™ Cy5 EGFP mRNA: Assay Design
2026-09-22
Learn how EZ Cap™ Cy5 EGFP mRNA (5-moUTP) can separate nanoparticle uptake from cytosolic release and translation. This article translates hyaluronate-LNP findings into a dual-reporter framework for more rigorous mRNA delivery decisions.
-
H2S Deficiency and ER Stress in Diabetic Cardiomyopathy
2026-09-22
Guo and colleagues identify reduced endogenous hydrogen sulfide production as a contributor to palmitate-associated lipotoxic injury in diabetic cardiomyopathy. Using patient samples, a streptozotocin-induced rat model, and AC16 cardiomyocytes, the study links H2S deficiency with ER stress, lipid accumulation, and apoptosis, while showing protective effects from H2S supplementation and ER-stress inhibition.
-
HyperFluor 488 Goat Anti-Mouse IgG: Lab Guide
2026-09-21
This scenario-based guide explains how HyperFluor™ 488 Goat Anti-Mouse IgG (H+L) Antibody, SKU K1204, can support reproducible immunofluorescence, flow cytometry, and western blot workflows. It connects reagent selection with controls, storage, safety, and interpretation of cell viability, proliferation, and cytotoxicity experiments.